1. Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity
   Daria Galas-Filipowicz et al, 2024, Frontiers in Oncology CrossRef
2. The MIP‐1α autocrine loop contributes to decreased sensitivity to anticancer drugs
   Masanobu Tsubaki et al, 2018, Journal of Cellular Physiology CrossRef
3. MicroRNA‑744 promotes cell apoptosis via targeting B�cell lymphoma‑2 in gastric cancer cell line SGC‑7901
   Jixiang Liu et al, 2018, Experimental and Therapeutic Medicine CrossRef
4. ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy
   Huimin Zhang et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
5. Soluble and Cell–Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma
   Mariah L. Farrell et al, 2018, Frontiers in Endocrinology CrossRef
6. Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability
   Maria Laura Pati et al, 2019, European Journal of Medicinal Chemistry CrossRef
7. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin
   Wei Han et al, 2018, International Journal of Oncology CrossRef
8. Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?
   Marek Z. Wojtukiewicz et al, 2017, Cancer and Metastasis Reviews CrossRef